A Study Of Valsartan Used To Treat Hypertension For Up To 13 Months In Hypertensive Children Ages 6 - 16 Years Of Age

Completed · Phase 3

Conditions studied: Hypertension

In brief

Drugs used to treat high blood pressure in adults should also be effective in treating high blood pressure in children and adolescents. This study will test the safety and efficacy of valsartan in treating high blood pressure in hypertensive children 6-16 years of age whose parent(s)/guardian(s) grant permission to participate.

Key facts

Study ID

NCT00171041

Run by

Novartis

People needed

265

Starts

2002-12-01

Expected to finish

2006-03-01

Last updated by the study team

2016-11-18

Who can join

Age: 6 and older, up to 16. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• CHILDREN HAVE SYSTOLIC BLOOD PRESSURE AT A LEVEL =>95th PERCENTILE FOR AGE/GENDER/HEIGHT
• CONSENT FROM PARENT(S)/GUARDIAN(S) MUST BE GRANTED

You may not qualify if…

• BLOOD PESSURE IS =>5% HIGHER THAN 99th PERCENTILE FOR AGE
• SERIOUS, CLINICALLY SIGNIFICANT FINDINGS UPON PHYSICAL EXAMINATION, AND LABORATORY AND OTHER ASSESSMENTS
• Other protocol-defined inclusion/exclusion criteria will also apply.

Where it is running

• Novartis Pharmaceuticals — E.Hanover, New Jersey, United States
• Study site — Investigative Centers, Germany

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.